Day: September 22, 2020

Firm Capital Apartment Real Estate Investment Trust Announces Closing of Previously Announced 50% Interest in a 235 Unit, Multi-Family Residential Building for $37.5 Million in the Washington D.C. Metro AreaAll amounts are in US Dollars unless otherwise stated.TORONTO, Sept. 22, 2020 (GLOBE NEWSWIRE) — Firm Capital Apartment Real Estate Investment Trust (the “Trust”), (TSXV: FCA.U), (TSXV: FCA) is pleased to announce it has closed the previously announced joint venture with an unrelated third party to acquire a $37.5 million multi-family residential property located in the Washington D.C. Metro Area.The Trust has closed the North Pointe Apartments (“North Pointe” or the “Property”), a 235-unit, multi-family residential property located in Hyattsville, Maryland. The joint venture purchased the property for $37.5 million or approximately $159,575 per unit...

TORONTO, Sept. 22, 2020 (GLOBE NEWSWIRE) — Evergold Corp. (TSX-V: EVER, OTC: EVGUF, FRA: 5EG) (“Evergold” or the “Company”) is pleased to announce the Company has completed the first tranche (“First Tranche”) of its previously announced (see news, August 28) non-brokered private placement (“the Offering”), which was primarily targeted at hard dollar investors, and exceeded it’s targeted sale of hard dollar units (“Units”). Because most institutional flow-through funds have depleted their capital by September, and several of these funds have indicated a desire to invest in the Company upon replenishing their reserves in early October, the Company intends to complete a second tranche (“Second Tranche”) involving several of these funds, thereafter. Prior to completing this second tranche, the Company will first receive back from the...

SÃO PAULO, Brazil, Sept. 22, 2020 (GLOBE NEWSWIRE) — StoneCo Ltd. (Nasdaq: STNE) (“Stone”), a leading provider of financial technology solutions that empower merchants to conduct commerce seamlessly across multiple channels, today announces that it will pursue the issuance of Brazilian Depositary Receipts (“BDR”).Following the announcements on August 11, 2020 and September 1, 2020 regarding Stone’s business combination with Linx (the “Transaction”), on September 22, 2020, Stone announced that it will pursue the issuance of BDRs. This will enable holders of shares of Linx traded in the Brazilian market to receive Stone BDRs as part of the consideration to be paid by STNE Participações S.A. to Linx shareholders in the context of the Transaction.This will be one of the first sponsored BDR – Level I programs in Brazil following...

TORONTO, Sept. 22, 2020 (GLOBE NEWSWIRE) — BlackRock Asset Management Canada Limited (BlackRock Canada), an indirect, wholly-owned subsidiary of BlackRock, Inc. (BlackRock) (NYSE:BLK) today announces that effective on or about December 1, 2020 the index that the iShares MSCI USA Momentum Factor Index ETF (the “iShares ETF”) seeks to replicate will change as follows:Both the Current Index and the New Index seek to provide exposure to U.S. equity securities identified by MSCI, Inc. (“MSCI”) as exhibiting positive momentum characteristics. The Current Index and the New Index will generally invest in the same equity securities. The Current Index and the New Index are generally rebalanced semi-annually, but each month may be rebalanced if the volatility of MSCI USA Index has increased above a threshold specified by MSCI; however, the...

TORONTO, 22 sept. 2020 (GLOBE NEWSWIRE) — Gestion d’actifs BlackRock Canada Limitée (« BlackRock Canada »), filiale indirecte en propriété exclusive de BlackRock, Inc. (« BlackRock ») (NYSE : BLK), annonce aujourd’hui qu’à compter du 1er décembre 2020 ou vers cette date, le iShares MSCI USA Momentum Factor Index ETF (le « FNB iShares ») reproduira le rendement d’un nouvel indice, soit le suivant :L’indice actuel et le nouvel indice visent à procurer une exposition aux titres de capitaux propres américains qui, selon MSCI, Inc. (« MSCI »), présentent des caractéristiques de momentum positives. L’indice actuel et le nouvel indice investiront, en général, dans les mêmes titres de capitaux propres. L’indice actuel et le nouvel indice sont, en général, rééquilibrés deux fois par année, mais ils pourraient être rééquilibrés chaque mois,...

EAGAN, Minn., Sept. 22, 2020 (GLOBE NEWSWIRE) — TumorGenesis, a division of Predictive Oncology (NASDAQ:POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, is pleased to announce that it has received a license for an additional 71 unique ovarian cancer cell lines and now has a total of 96 unique patient derived cells all acquired from ovarian cancer patients. These cell lines were licensed from the English company, Ximbio, the world’s largest non-profit dedicated to life science reagents of all kinds.Richard Gabriel, President of TumorGenesis, commented, “It is remarkable that the UK cancer researchers using the same media mixes now being offered by TumorGenesis for researchers around the world, independently isolated, and identified another unique set...

MCLEAN, Va., Sept. 22, 2020 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) has priced a new offering of Structured Pass-Through Certificates (K Certificates), which includes a class of floating rate bonds indexed to the Secured Overnight Financing Rate (SOFR). The approximately $968 million in K Certificates (K-F85 Certificates) are expected to settle on or about September 30, 2020. The K-F85 Certificates are backed by floating-rate multifamily mortgages with 10-year terms, which are currently LIBOR-based.K-F85 includes one class (Class AL) of senior bonds indexed to LIBOR and another class (Class AS) of senior bonds indexed to SOFR. Freddie Mac will provide a basis risk guarantee on Class AS that covers any floating interest rate basis risk if the value of SOFR exceeds the value of LIBOR.K-F85 PricingDetailsCo-Lead Managers and Joint...

Company AnnouncementCopenhagen, Denmark; September 22, 2020 – Genmab A/S (Nasdaq: GMAB) announced today that it has commenced binding arbitration of two matters arising under its license agreement with Janssen Biotech, Inc. (Janssen) relating to daratumumab. Under the license agreement, Genmab is, among other things, entitled to royalties from Janssen on sales of daratumumab (marketed as DARZALEX® for intravenous administration and, in the United States, as DARZALEX FASPRO™ for subcutaneous administration).The arbitration first is to settle whether Genmab is required to share in Janssen’s royalty payments to Halozyme Therapeutics, Inc. for the Halozyme enzyme technology used in the subcutaneous formulation of daratumumab. The royalties Janssen pays to Halozyme represent a mid-single digit percentage rate of subcutaneous daratumumab sales....

ALTAVISTA, Va. and DANVILLE, Va., Sept. 22, 2020 (GLOBE NEWSWIRE) — Pinnacle Bankshares Corporation (OTCQX: PPBN) (“Pinnacle” or the “Company”), the holding company for First National Bank, and Virginia Bank Bankshares, Inc. (OTC Pink: VABB) (“Virginia Bank”), the holding company for Virginia Bank and Trust, today jointly announced that they have received all required bank regulatory approvals for the pending merger of Virginia Bank into Pinnacle.“We are extremely pleased to have the approvals from the OCC, the Federal Reserve and the Virginia State Corporation Commission for the merger,” stated Aubrey H. “Todd” Hall, III, Pinnacle’s President and Chief Executive Officer. He further commented, “Together Pinnacle and Virginia Bank will be well positioned to serve our communities and generate enhanced returns for our shareholders....

TORONTO, Sept. 22, 2020 (GLOBE NEWSWIRE) — ABERDEEN INTERNATIONAL INC. (“Aberdeen” or the “Company”) (TSX: AAB) has acquired 5,000,000 units of Jourdan Resources Inc. (“Jourdan”) (TSX-V: JOR) in a non-brokered private placement financing of Jourdan at a price of $0.015 per unit for a total subscription price of $75,000.     Each unit is comprised of one Jourdan common share and one Jourdan common share purchase warrant.    Each common share purchase warrant is exercisable for one common share of Jourdan at a price of $0.05 for a period of 24 months.Prior to this transaction, Aberdeen owned 8,333,333 common shares of Jourdan, representing approximately 14.2% of the then issued and outstanding shares on a non-diluted basis. As a result of this transaction, Aberdeen owns 13,333,333 Jourdan shares and 5,000,000 Jourdan common share...